Published in Med Biol Eng Comput on July 01, 1992
Electrochemotherapy in treatment of tumours. Eur J Surg Oncol (2007) 2.51
Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer (1998) 2.11
Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res (1995) 1.85
The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J (1998) 1.61
Analytical description of transmembrane voltage induced by electric fields on spheroidal cells. Biophys J (2000) 1.59
Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis. Eur J Surg Oncol (2012) 1.55
Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer (2008) 1.53
Electrochemotherapy: a new technological approach in treatment of metastases in the liver. Technol Cancer Res Treat (2011) 1.50
Efficiency of high- and low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin. Hum Gene Ther (2008) 1.39
Electrically-assisted nucleic acids delivery to tissues in vivo: where do we stand? Curr Pharm Des (2006) 1.31
Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. Clin Cancer Res (2000) 1.19
Prognostic factors in the prediction of chronic wound healing by electrical stimulation. Med Biol Eng Comput (2001) 1.15
Increasing the repetition frequency of electric pulse delivery reduces unpleasant sensations that occur in electrochemotherapy. Neoplasma (2007) 1.12
The effect of pulse repetition frequency on the uptake into electropermeabilized cells in vitro with possible applications in electrochemotherapy. Bioelectrochemistry (2002) 1.11
Tumor blood flow modifying effect of electrochemotherapy with bleomycin. Anticancer Res (2000) 1.11
Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients. Eur J Cancer (1998) 1.10
Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin. Br J Cancer (1999) 1.05
Numerical determination of transmembrane voltage induced on irregularly shaped cells. Ann Biomed Eng (2006) 1.05
Role of pulse shape in cell membrane electropermeabilization. Biochim Biophys Acta (2003) 1.04
Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy. Br J Cancer (2001) 1.03
Cell membrane electropermeabilization by symmetrical bipolar rectangular pulses. Part I. Increased efficiency of permeabilization. Bioelectrochemistry (2001) 1.01
Electrochemotherapy in veterinary oncology. J Vet Intern Med (2008) 0.99
The influence of medium conductivity on electropermeabilization and survival of cells in vitro. Bioelectrochemistry (2001) 0.98
Determination of the lipid bilayer breakdown voltage by means of linear rising signal. Bioelectrochemistry (2006) 0.97
Parameters of postocclusive reactive hyperemia measured by near infrared spectroscopy in patients with peripheral vascular disease and in healthy volunteers. Ann Biomed Eng (2001) 0.96
Anti-tumor effectiveness of electrochemotherapy with bleomycin is increased by TNF-alpha on SA-1 tumors in mice. Cancer Lett (1997) 0.95
Second-order model of membrane electric field induced by alternating external electric fields. IEEE Trans Biomed Eng (2000) 0.95
Control by pulse parameters of DNA electrotransfer into solid tumors in mice. Gene Ther (2009) 0.94
Electrochemotherapy with cisplatin: the systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastases. Melanoma Res (2000) 0.93
Cell membrane electropermeabilization by symmetrical bipolar rectangular pulses. Part II. Reduced electrolytic contamination. Bioelectrochemistry (2001) 0.93
Electric current density imaging of mice tumors. Magn Reson Med (1997) 0.92
Reproducibility of parameters of postocclusive reactive hyperemia measured by near infrared spectroscopy and transcutaneous oximetry. Ann Biomed Eng (2000) 0.91
Muscle gene electrotransfer is increased by the antioxidant tempol in mice. Gene Ther (2011) 0.91
A reliable method of determining wound healing rate. Med Biol Eng Comput (2001) 0.89
Modelling of chronic wound healing dynamics. Med Biol Eng Comput (2000) 0.89
Intrinsic sensitivity of tumor cells to bleomycin as an indicator of tumor response to electrochemotherapy. Jpn J Cancer Res (1998) 0.89
Intratumoral cisplatin administration in electrochemotherapy: antitumor effectiveness, sequence dependence and platinum content. Anticancer Drugs (1998) 0.88
Evaluation of cell membrane electropermeabilization by means of a nonpermeant cytotoxic agent. Biotechniques (2000) 0.87
Theoretical evaluation of the distributed power dissipation in biological cells exposed to electric fields. Bioelectromagnetics (2000) 0.86
Calculation of the electrical parameters in electrochemotherapy of solid tumours in mice. Comput Biol Med (1998) 0.86
The temperature effect during pulse application on cell membrane fluidity and permeabilization. Bioelectrochemistry (2008) 0.85
Electrochemotherapy with bleomycin in SA-1 tumor-bearing mice--natural resistance and immune responsiveness. Anticancer Drugs (1996) 0.85
Electrochemotherapy with cisplatin in the treatment of tumor cells resistant to cisplatin. Anticancer Res (1999) 0.84
The effect of the histological properties of tumors on transfection efficiency of electrically assisted gene delivery to solid tumors in mice. Gene Ther (2007) 0.84
Inhibition of SA-1 tumor growth in mice by human leukocyte interferon alpha combined with low-level direct current. Mol Biother (1990) 0.84
Efficient electrotransfection into canine muscle. Technol Cancer Res Treat (2008) 0.84
MicroRNAs targeting mutant K-ras by electrotransfer inhibit human colorectal adenocarcinoma cell growth in vitro and in vivo. Cancer Gene Ther (2010) 0.84
Cell counting tool parameters optimization approach for electroporation efficiency determination of attached cells in phase contrast images. J Microsc (2010) 0.84
Modification of TNF-alpha pharmacokinetics in SA-1 tumor-bearing mice. Int J Cancer (1993) 0.84
Determination of platinum in tumour tissues after cisplatin therapy by electrothermal atomic absorption spectrometry. J Pharm Biomed Anal (1997) 0.83
Electrochemotherapy of tumours. Curr Oncol (2009) 0.82
Electrochemotherapy of tumours resistant to cisplatin: a study in a murine tumour model. Eur J Cancer (2001) 0.81
Gene electrotransfer of siRNAs against CD146 inhibits migration and invasion of human malignant melanoma cells SK-MEL28. Cancer Gene Ther (2013) 0.81
Electric treatment of human melanoma skin lesions with low level direct electric current: an assessment of clinical experience following a preliminary study in five patients. Eur J Surg Suppl (1994) 0.81
Effect of hydralazine on interstitial fluid pressure in experimental tumours and in normal tissue. In Vivo (2001) 0.80
Changed delivery of boron to tumours using electroporation for boron neutron capture therapy with BSH. Br J Radiol (2000) 0.79
Electrochemotherapy: potentiation of local antitumour effectiveness of cisplatin in dogs and cats. Anticancer Res (2001) 0.79
An algorithm for synchronization of in vivo electroporation with ECG. J Med Eng Technol (2005) 0.79
Blood perfusion of subcutaneous tumours in mice following the application of low-level direct electric current. Adv Exp Med Biol (1999) 0.78
Potentiation of bleomycin antitumor effectiveness by electrotherapy. Cancer Lett (1993) 0.77
The influence of TNF on the membrane fluidity of tumor cells. Cancer Lett (1992) 0.77
Treatment of chronic wounds by means of electric and electromagnetic fields. Part 1. Literature review. Med Biol Eng Comput (1992) 0.77
EPR oximetry: reduction of cell respiration by vinblastine. Pflugers Arch (1996) 0.75
Anti-tumor effect of electrotherapy alone or in combination with interleukin-2 in mice with sarcoma and melanoma tumors. Anticancer Drugs (1992) 0.75
Antitumor effectiveness of bolus versus split dose vinblastine treatment in EAT tumors in mice. Anticancer Res (1998) 0.75
New TNF-alpha analogues: a powerful but less toxic biological tool against tumours. Cytokine (1997) 0.75
Anti-tumor effect of tumor necrosis factor combined with electrotherapy on mouse sarcoma. Anticancer Drugs (1994) 0.75
In vitro monocyte maturation in patients with malignant melanoma and colorectal cancer--clinical significance. Neoplasma (1986) 0.75
Adoptive immunotherapy as an adjunctive treatment to thoracic irradiation for pulmonary tumor deposits in mice. Cancer Res (1989) 0.75
Effect of vinblastine on cell membrane fluidity in vinblastine-sensitive and -resistant HeLa cells. Cancer Lett (1998) 0.75
Cytotoxicity of bioreductive drug tirapazamine is increased by application of electric pulses in SA-1 tumours in mice. Anticancer Res (2001) 0.75
Searching for new TNF-alpha analogs having potential application in cancer therapy. Pflugers Arch (1996) 0.75
Interactions of interferon and vinblastine on experimental tumor model melanoma B-16 in vitro. Anticancer Drugs (1994) 0.75